Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data is a research paper published in Drugs & Aging (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute on Aging
Grant: K08AG051187
National Institute on Aging
Grant: R01AG062713
National Institute on Aging
Grant: R01AG071809
National Institute on Aging
Grant: K24AG073527
National Institutes of Health
Grant: 1K24AG073527-01A1
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
National Institutes of Health
Grant: 5R01AG062713-02
Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty
National Institutes of Health
Grant: 5K08AG051187-02
Development and Validation of a Frailty Index Using Claims Data for Pharmacoepidemiologic Studies in Older Adults
National Institutes of Health
Grant: 5R01AG071809-04
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
FWCI
0.53
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords